9/29/2011 3:29 pm Date / Time filed with the Register of Regulations | VA.R. Document Number: R____-______ |
Virginia Register Publication Information
|
Transmittal Sheet: Response to Petition for Rulemaking
Initial Agency Notice
X
Agency Decision
Promulgating Board: | Board of Pharmacy |
Regulatory Coordinator: | Caroline Juran, RPh (804)367-4416 caroline.juran@dhp.virginia.gov |
Agency Contact: | Elaine J. Yeatts Agency Regulatory Coordinator ()- elaine.yeatts@dhp.virginia.gov |
Contact Address: | Department of Health Professions 9960 Mayland Drive, Suite 300 Richmond, VA 23233 |
Chapter Affected: | |
18 vac 110 - 20: | Virginia Board of Pharmacy Regulations |
Statutory Authority: |
State: Chapters 33 and 34 of Title 54.1 Federal: |
Date Petition Received | 05/27/2011 |
Petitioner | Karen Dunavant, Courtney Fuller and Annette Reichenbaugh |
Amend requirement for monthly inspection of automated dispensing devices by pharmacy
personnel to verify proper storage, location of drugs, expiration dates, drug security
and validity of access codes.
Agency Plan
The Board will publish the petitions on June 20, 2011 and request 21 days of public
comment ending July 11, 2011. The Board will consider the petitions and comments
received at its meeting on September 22, 2011 to determine whether to initiate a regulatory
action.
Publication Date | 06/20/2011 (comment period will also begin on this date) |
Comment End Date | 07/11/2011 |
Initiate a regulatory change
Agency Response Date | 09/29/2011 |
The Board of Pharmacy received three petitions for rulemaking from hospital pharmacists
requesting an amendment to #5 of section 490 in Chapter 20, which provides requirements
for automated devices for dispensing and administration of drugs. The petitioners
requested less burdensome requirements for verification of storage, location, expiration
dates, drug security and validity of access codes.
While the Board agreed that the petition was reasonable and the specific requirements
in #5 may need to be modified for consistency with current technology, it concluded
that all of section 490 should be examined for possible amendments that would ensure
drug security and integrity but would make compliance less burdensome.